I would take the narrow conclusion. Broad ones are more interesting and less true.

Baseline first. Without a baseline the after picture is decoration.

Imprint databases are mostly US-centric. A confident hit for another market is still a guess.

Ten percent cuts, of the current dose not the original. That is the arithmetic that keeps it survivable. Same for me with pharmacy work, unfortunately…

Enteric coatings should not be crushed. The pellets are the delivery mechanism. Same for me with a laptop battery, unfortunately.